Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 222,248 shares at $27.01 ($5.7M) on 2024-07-23, disclosed to the SEC on 2024-07-25.
Scheduled sale ($5.7M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.25 | 23,075 | $536K | 9.4% |
| 2 | $23.25 | 23,075 | $536K | 9.4% |
| 3 | $25.05 | 50,000 | $1.3M | 21.9% |
| 4 | $27.01 | 63,049 | $1.7M | 29.7% |
| 5 | $27.01 | 63,049 | $1.7M | 29.7% |
| Total | $25.79 avg | 222,248 |
| $5.7M |
| 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |